ASX-LISTED skin care and health products company Bod Australia has announced a supply and collaboration agreement with Swiss herbal extracts company Linnea Natural Pharma Solutions, maker of proprietary cannabis extracts.
Paths to market under evaluation include therapeutic products for treating multiple sclerosis, epilepsy and chemotherapyinduced nausea and vomiting.
Bod said it would also develop cosmetics & topical skin care items based on Linnea's NioSkin range of active cosmetic ingredients.
The above article was sent to subscribers in Pharmacy Daily's issue from 24 Oct 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 24 Oct 17